Our data identifies CCL27 and CXCL13 as putative, plausibly homeostatic/protective biomarkers for BMS-COPD within the investigated population that warrants validation in larger and multiple cohorts. The gene discussed is CXCL13; the disease is chronic obstructive pulmonary disease.